IQVIA Holdings Inc.

NYSE:IQV

Medical - Diagnostics & Research

Healthcare
$257.84 -1.83%

-$3.13 today

Market cap
$42.49B
Beta
1.22
P/E (TTM)
20.4
EPS (TTM)
$8.22
52W Low $153.01High $247.05

Volume 1.40M

Average 1.62M

IQV Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

IQVIA Holdings Inc.NYSE: IQV

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin holds steady near 32.9%

Gross margin was 32.9% in Q2 FY2026, down 0.1 pp from a year earlier. On a trailing-twelve-month basis it was 26.2%, down 8.0 pp year over year. Over 3 fiscal years it narrowed by 1.6 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
32.9%+0.2 pp QoQ
Last fiscal yearDec 2025
33.3%-1.6 pp YoY
LTMJun 2026
26.2%-8.0 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-0.1 pp——
1 year-1.6 pp——
3 years-1.6 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
33.3%
Year-over-year change
-1.6pp

Gross Margin vs competitors

How IQV compares with its peers on the latest reported figures

  • IQV's LTM Jun 2026 gross margin of 26.2% is the 7th highest of the 9 companies compared; the peer median is 39.1%.
  • Its year-over-year change of -8.0 pp is the lowest of 9, against a peer median of -1.3 pp.
  • Over three fiscal years its change of -1.6 pp compares with a peer median of -0.9 pp.
IQV Competitors Peer median
Gross Margin for IQV and competitors
Company Period LTM level YoY 3-year change
VEEVVeeva Systems Inc.LTM Jul 202674.9% -0.7 pp+3.8 pp
TEMTempus AI, Inc.LTM Sep 202666.5% +4.8 pp+22.1 pp
CERTCertara, Inc.LTM Mar 202658.1% -2.1 pp+1.0 pp
HCATHealth Catalyst, Inc.LTM Mar 202646.0% +0.7 pp-14.7 pp
CRLCharles River Laboratories International, Inc.LTM Jun 202632.2% -0.2 pp-6.3 pp
MEDPMedpace Holdings, Inc.LTM Sep 202629.1% -2.0 pp+0.4 pp
IQVIQVIA Holdings Inc.LTM Jun 202626.2% -8.0 pp-1.6 pp
ICLRICON Public Limited CompanyLTM Jun 202621.8% -6.7 pp-2.2 pp
FTREFortrea Holdings Inc.LTM Jun 202617.1% -1.9 pp-9.9 pp
Peer median (excluding IQV) 39.1%-1.3 pp-0.9 pp

Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.87B14.41B14.98B15.41B16.31B
Cost of Revenue9.23B9.38B9.75B10.03B10.88B
Gross Profit4.64B5.03B5.24B5.38B5.43B
Gross Margin33.5%34.9%35.0%34.9%33.3%
Research & Development00000
Selling, General & Admin1.96B2.07B2.05B1.99B1.99B
Operating Expenses3.25B3.23B3.26B3.17B3.25B
Depreciation & Amortization1.26B1.13B1.13B1.11B640M
EBITDA2.77B2.91B3.26B3.45B2.94B
EBITDA Margin19.9%20.2%21.7%22.4%18.0%
Operating Income1.39B1.8B1.98B2.2B2.18B
Operating Margin10.0%12.5%13.2%14.3%13.4%
Interest Income6M13M36M47M45M
Interest Expense375M416M672M670M729M
Other Income / Expenses(259M)(448M)(518M)(533M)(569M)
Income Before Tax1.13B1.35B1.46B1.67B1.61B
Pre-Tax Margin8.2%9.4%9.7%10.8%9.9%
Income Tax Expense163M260M101M296M252M
Net Income966M1.09B1.36B1.37B1.36B
Net Margin7.0%7.6%9.1%8.9%8.3%
EPS (Basic)5.055.827.397.577.91
EPS (Diluted)4.955.727.297.497.84
Weighted Avg Shares191.4M187.6M183.8M181.3M171.9M
Weighted Avg Shares (Diluted)195M190.6M186.3M183.4M173.5M

IQVIA Holdings Inc.

NYSE:IQV

Intrinsic Alpha fair value

Locked

Current Price

$257.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.